It bypasses the digestive system, ensuring faster and more effective absorption to support energy production, nerve health, and overall well-being
Given the shift towards pharmaceutical intervention in obesity management, GLP-1 therapies are expected to account for a substantial share of this growth
Dong Y, Yang Y, Liu J, Awan F, Lu C, Liu Y (2018) Inhibition of Aeromonas hydrophila -induced intestinal inflammation and mucosal barrier function damage in crucian carp by oral administration of Lactococcus lactis
As GLP-1 medications become more common across the population, foodservice teams in senior living and adult care facilities are increasingly serving residents whose appetites and needs are evolving
Arvanitakis, K., Koufakis, T., Popovic, D., Maltese, G., Mustafa, O., Doumas, M., Giouleme, O., Kotsa, K., & Germanidis, G